Award boosts access to T-cell receptor gene sequencing service
July 26, 2010
The Fred Hutchinson Cancer Research Center Public Health Sciences Division’s Dr. Harlan Robins received a commercialization grant worth $150,000 from the Washington State Life Sciences Discovery Fund. He will use the monies to enhance a DNA sequencing technology to profile T-cells within the immune system.
Dr. Jennifer Adair, a researcher in the Fred Hutchinson Cancer Research Center Clinical Research Division’s Kiem Lab, recently received an Excellence in Research award from the American Society of Gene & Cell Therapy. Adair presented her award-winning work at ASGCT’s annual meeting in Washington, D.C., last month.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.